European patients get slower access to cancer drugs than US peers

But they pay more and it’s not clear if outcomes are better Related items from OnMedica Find the money for this diabetes drug, NICE tells trusts Government scraps plans to replace brand drugs with generics in primary care Changes to prescription charges are delayed until autumn Poor quality and fake drugs threaten global efforts to control malaria 25% variation in per capita drug spend across European Union

via OnMedica News Read More Here..